Cholesterol Metabolism

Cholesterol has a reputation as something purely harmful, but it's actually essential to normal physiology. This subtopic covers where cholesterol comes from, how its synthesis is regulated, and how it's transported and redistributed once it's in the blood.

Key Takeaways

• Cholesterol is a structural membrane component and the precursor for steroid hormones, bile acids, and vitamin D.

• Cholesterol synthesis occurs mainly in the liver, starting from acetyl-CoA and requiring NADPH.

• HMG-CoA reductase is the rate-limiting, feedback-inhibited enzyme of cholesterol synthesis — inhibited by high cholesterol, stimulated by high insulin — and the pharmacological target of statin drugs.

• Because cholesterol is hydrophobic, it's carried through blood within lipoproteins as cholesteryl esters.

• LCAT converts free cholesterol into cholesteryl esters within HDL; CETP transfers those cholesteryl esters between lipoprotein classes.

• Cholesterol metabolism as a whole balances synthesis, transport, utilization, and removal.

Why the Body Needs Cholesterol

Cholesterol is a ubiquitous component of nearly every cell in the human body, found in cell membranes throughout all tissues, where it plays a structural role by helping regulate membrane fluidity and stability.

Beyond membranes, cholesterol is also a precursor molecule for several critical substances:

• Steroid hormones

• Bile acids

• Vitamin D

Because of these roles, cholesterol isn't simply a dietary molecule — it's an essential biochemical building block.

Cholesterol Synthesis: The Liver, Acetyl-CoA, and NADPH

Some cholesterol comes from the diet, but the body is fully capable of producing its own. Cholesterol is synthesized mainly in the liver, starting from acetyl-CoA. This synthesis requires energy and reducing power, supplied in the form of NADPH.

HMG-CoA Reductase: The Rate-Limiting, Regulated Step

The most important step in cholesterol synthesis — the rate-limiting step — is catalyzed by the enzyme HMG-CoA reductase. This enzyme controls how fast cholesterol is made, and because cholesterol levels must be carefully managed, it's tightly controlled by the cell.

Feedback Inhibition and Insulin's Role

When cholesterol levels are high, cholesterol feeds back to inhibit HMG-CoA reductase — a classic example of feedback inhibition. When insulin levels are high (such as after a meal), cholesterol synthesis is stimulated, since the body is in a nutrient-rich state and can afford to build complex molecules. When energy is low, cholesterol synthesis slows down.

Real-World Relevance: Statins

Because HMG-CoA reductase is the rate-limiting enzyme of cholesterol synthesis, it's also the target of statin drugs — one of the most widely prescribed medication classes for lowering blood cholesterol. Statins work as competitive inhibitors: they bind the enzyme's active site with far higher affinity than its natural substrate, blocking the conversion step and reducing the liver's cholesterol output.

Transporting Cholesterol: Cholesteryl Esters and Lipoproteins

Once cholesterol is synthesized or absorbed from the diet, it must travel through the bloodstream. But cholesterol is hydrophobic, so it can't move freely in blood — it's carried within lipoproteins.

Cholesterol in the blood is often converted into a storage and transport form called cholesteryl esters. This conversion allows cholesterol to be packed into the core of lipoprotein particles. Two important enzymes manage this process and redistribute cholesterol between lipoproteins.

LCAT and CETP: Managing Cholesterol Redistribution

LCAT (lecithin-cholesterol acyltransferase) converts free cholesterol into cholesteryl esters within high-density lipoproteins (HDL). This lets HDL collect cholesterol from tissues and prepare it for transport.

CETP (cholesteryl ester transfer protein) transfers cholesteryl esters between different lipoproteins — for example, from HDL to LDL or VLDL. This redistribution helps direct cholesterol either toward tissues that need it or back to the liver.

Through the coordinated action of lipoproteins and enzymes like LCAT and CETP, cholesterol can be delivered to body tissues for membrane synthesis and hormone production, or returned to the liver for recycling or disposal as bile acids.

Common MCAT Mistakes

• Assuming statins block cholesterol absorption from food. Statins act on HMG-CoA reductase, the rate-limiting enzyme of synthesis, not on dietary uptake — they lower the liver's own cholesterol output, not gut absorption.

• Thinking high insulin inhibits cholesterol synthesis like it does other catabolic pathways. It's the opposite here: high insulin (the well-fed state) stimulates HMG-CoA reductase and cholesterol synthesis, since the body has surplus energy to build complex molecules. Feedback inhibition comes from cholesterol itself, not from insulin.

• Confusing LCAT and CETP. LCAT converts free cholesterol into cholesteryl esters within HDL; CETP doesn't create esters — it transfers already-esterified cholesterol between lipoprotein particles (e.g., HDL to LDL/VLDL).

• Treating cholesterol as purely a dietary/harmful molecule. It's a required structural component of every cell membrane and the direct precursor for steroid hormones, bile acids, and vitamin D — the body synthesizes its own supply even without dietary intake.

MCAT-Style Concept Check

Question: A researcher adds a drug to liver cells that competitively inhibits HMG-CoA reductase. Which of the following is the most direct downstream effect?

• A) Cholesteryl ester transfer between HDL and LDL increases

• B) Dietary cholesterol absorption in the intestine decreases

• C) The rate-limiting step of cholesterol synthesis is slowed, lowering cholesterol output

• D) LCAT activity within HDL is directly inhibited

Answer: C

Explanation: HMG-CoA reductase catalyzes the rate-limiting step of cholesterol synthesis, so competitively inhibiting it (the mechanism statins use) slows that step and reduces how much cholesterol the liver produces. CETP-mediated transfer (A) and LCAT activity (D) are separate enzymes not directly acted on by an HMG-CoA reductase inhibitor. Dietary absorption (B) is a gut process unrelated to a liver synthesis enzyme.

FAQ

Where does the body get cholesterol from?

Cholesterol comes from two sources: the diet, and the body's own synthesis, which occurs mainly in the liver starting from acetyl-CoA and requiring NADPH.

Why is HMG-CoA reductase important for the MCAT?

It's the rate-limiting, feedback-inhibited enzyme of cholesterol synthesis — inhibited by high cholesterol, stimulated by high insulin — and it's the direct pharmacological target of statin drugs, which competitively block its active site.

What's the difference between LCAT and CETP?

LCAT converts free cholesterol into cholesteryl esters within HDL. CETP then transfers those cholesteryl esters between different lipoproteins, such as from HDL to LDL or VLDL, redistributing cholesterol toward tissues or back to the liver.

Why can't cholesterol travel freely in the blood?

Cholesterol is hydrophobic, so it can't dissolve in the watery bloodstream on its own. It's converted into cholesteryl esters and packed into the core of lipoprotein particles for transport.